全部商品分类
1/2
产品介绍
产品介绍
产品信息
商品描述
Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren‘s syndrome.

分子量
489.55

纯度
>98%

可溶性
H2O : ≥ 50 mg/mL (204.27 mM)

外观
white to tan powder

In vitro(体外研究)
In digested parotid cells, Cevimeline (0.1-100 μM) increases the intracellular Ca2+ concentration.

In vivo(体内研究)
Cevimeline (0.008-0.016 mg/kg; intraperitoneal injection; male Wistar rats) treatment shows slowly increasing and lasting salivation, and increased blood flow increment in the parotid gland and pressor response. Cevimeline inhibits angiotensin II-induced water intake and neuronal activity in the subfornical organ at 0.016 mg/kg.

背景
别名
盐酸西维美林半水合物;SNI-2011;AF102B hydrochloride hemihydrate

分子式
C20H38Cl2N2O3S2

CAS号
153504-70-2

制备和贮存
保存方式
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。






.jpg)
用小程序,查商品更便捷


